Quanterix Corporation

QTRX Healthcare Medical Devices

Quanterix Corporation’s revenue for fiscal 2025 (year ended December 2025) was $138.9 million, up 1.07% from fiscal 2024. In the quarter to June 2026, revenue grew 34.4%, EPS fell 35.1% and free cash flow grew 18.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

2.87 0.20 −6.51%
Market cap
$145.2M
P/E
0.0×
Fwd P/E
−2.6×
Dividend yield
—
F-score
3/9
Altman Z
−0.87
Beneish M
−0.69
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
118.23 289.12 321.32 338.74 396.47 181.58 109.16 44.43 79.68 29.67
Receivables
29.97 32.14 25.41 19.02 23.79 17.18 10.91 6.79 5.60 3.92
Inventory
54.76 32.78 26.12 16.96 22.19 14.86 10.46 5.95 3.57 1.53
Total current assets
212.26 363.59 382.10 381.52 448.96 219.61 132.66 59.50 89.25 35.24
Property, Plant, Equpment (Net)
23.67 17.15 17.93 19.81 17.96 13.91 12.05 2.92 1.87 1.22
Goodwill and Intangible Assets (Total)
158.16 4.03 6.03 7.52 20.17 24.18 23.66 3.66 — —
Long-term assets (Other)
8.01 5.42 4.26 3.51 2.96 1.36 1.58 1.54 0.65 0.65
Total non-current assets
206.51 42.94 46.47 52.06 52.57 51.44 37.29 8.12 2.53 1.87
Total Assets
418.77 406.53 428.57 433.58 501.53 271.05 169.95 67.61 91.78 37.12
Accounts Payable
13.57 6.95 5.05 3.84 9.21 6.80 5.78 5.11 3.55 2.55
Accrued Expenses
32.55 21.47 20.23 16.18 13.25 10.78 6.57 4.45 2.62 1.69
Current Part of Debt
— — — — — 7.67 0.08 — 5.04 0.90
Current Revenue (Deferred)
20.73 8.83 9.47 8.64 6.36 5.42 4.70 5.44 4.94 3.43
Other current liabilities
— — — — 0.24 3.05 0.22 13.02 11.13 7.51
Total current liabilities
74.76 42.01 38.98 31.35 36.98 39.80 19.83 18.13 19.71 10.96
Long Term Debt (Total)
— — — — — — 7.59 7.62 4.35 9.34
Non-current Revenue (Deferred)
5.83 1.07 1.23 1.42 1.10 0.58 0.47 0.52 1.71 0.33
Long Term Tax Liability (Deferred)
— — — — — 2.65 2.83 — — —
Liabilities (Preferred Stock)
— — — — — — — — — 2.80
Non-current Liabilities (Other)
13.12 0.80 1.18 1.47 2.04 2.65 13.41 0.28 0.14 0.21
Total non-current liabilities
48.27 34.49 39.63 44.30 23.60 25.12 21.46 8.42 6.20 12.69
Total liabilities
123.04 76.50 78.61 75.65 60.58 64.92 41.29 26.55 25.91 23.64
Additional Paid In Capital
873.64 803.16 783.14 763.63 745.94 451.43 345.03 216.93 210.20 —
Preferred Stock (Total)
— — — — — — — — — 128.59
Common Stock (Net)
0.05 0.04 0.04 0.04 0.04 0.03 0.03 0.02 0.02 0.00
Retained Earnings
(577.23) (470.08) (431.55) (403.20) (305.46) (247.77) (216.24) (175.89) (144.35) (115.11)
Common Equity (Total)
295.73 330.04 349.96 357.93 440.95 206.13 128.66 41.07 65.87 (115.11)
Shareholders Equity (Total)
295.73 330.04 349.96 357.93 440.95 206.13 128.66 41.07 65.87 13.48
Shareholders Equity and Liabilities (Total)
418.77 406.53 428.57 433.58 501.53 271.05 169.95 67.61 91.78 37.12
Shares (Common)
46.74 38.57 38.01 37.28 36.77 31.80 28.11 22.37 21.71 2.32
Shares (Preferred)
— — — — — — — — — 42.75
Shareholders Equity (Tangible)
137.57 326.01 343.92 350.42 420.79 181.95 105.00 37.41 65.87 13.48
Net Debt
(118.23) (289.12) (321.32) (338.74) (396.46) (173.91) (101.49) (36.81) (70.30) (19.43)
Total Debt
— — — 44.10 21.89 7.67 7.66 7.62 9.38 10.24

Fold the line items

In millions of $ except per-share values · columns are period end dates